Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Conflu3nce
Conflu3nce Overview
Conflu3nce applies its patented methods to the early detection of cognitive health changes in people across the cognitive spectrum. The company is developing PICSSi, a minimally-disruptive, on-demand system that addresses cognitive-motor issues for people across a wide range of ages and conditions, including Alzheimers disease, traumatic brain injury, Parkinsons disease, stroke, and attention-deficit/hyperactivity disorder.
The systems multi-modal, multi-domain-based personalized interactive units are designed to cooperatively engage global cognition and can be delivered as hands-on or virtual/view-only experiences. The company's PICSSi and Stitch and Peel (SnP) technology is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with image properties that can be manipulated and predicted.
For early detection, PICSSi can be personalized to capture an individuals cognitive expression pattern without bias toward disease/symptom trajectories or domain-specific deficits. User-specific baselines are used to detect changes in cognition over time. And for training/remediation, users are guided through increasingly challenging interactions to develop and retrain their skills, processes, and processing based on their dynamic progress.